Cormark Analysts Cut Earnings Estimates for CRH Medical Corp (CRH)
CRH Medical Corp (TSE:CRH) – Stock analysts at Cormark decreased their FY2017 earnings estimates for CRH Medical Corp in a research report issued to clients and investors on Thursday. Cormark analyst D. Novak now anticipates that the company will post earnings per share of $0.15 for the year, down from their previous estimate of $0.17. Cormark also issued estimates for CRH Medical Corp’s Q4 2017 earnings at $0.09 EPS, Q1 2018 earnings at $0.04 EPS, Q4 2018 earnings at $0.06 EPS and FY2018 earnings at $0.22 EPS.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.watchlistnews.com/cormark-analysts-cut-earnings-estimates-for-crh-medical-corp-crh/1684167.html.
A number of other equities research analysts have also weighed in on CRH. Scotiabank lowered CRH Medical Corp from an “outperform” rating to a “sector perform” rating and dropped their price target for the stock from C$10.00 to C$8.00 in a research note on Friday, July 14th. TD Securities dropped their price target on CRH Medical Corp from C$10.50 to C$10.00 and set a “buy” rating on the stock in a research note on Friday, July 14th. Royal Bank Of Canada boosted their price target on CRH Medical Corp from C$8.50 to C$10.00 and gave the stock a “sector perform” rating in a research note on Monday, July 17th. National Bank Financial dropped their price target on CRH Medical Corp from C$9.00 to C$7.00 in a research note on Monday, July 17th. Finally, Bloom Burton lowered CRH Medical Corp from a “buy” rating to an “accumulate” rating in a research note on Friday, July 14th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of C$3.88.
Shares of CRH Medical Corp (TSE CRH) opened at C$2.19 on Monday.
About CRH Medical Corp
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.